FDA Announces Review of Opioid Prescribing Regulations and Framework for Preventing Overdose-Related Deaths | Mintz - Health Care Viewpoints
The head of the Food and Drug Administration (FDA), Dr. Robert Califf, announced on August 30, 2022 that, in addition to an extensive review of opioid regulations, the agency is...